FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lois Jeanne Ayash

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Muneer H Abidi; Judith Abrams; Rishi Agarwal; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Abhinav Deol; Lawrence George Lum; Voravit Ratanatharathorn; Nishant Tageja; Marie Ventimiglia; Jeffrey A Zonder; Joseph Primo Uberti
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.
Zaid Al-Kadhimi; Lois Jeanne Ayash; Wei Chen; Abhinav Deol; Stephen Forman; Zartash Gul; Lawrence George Lum; Alice Mitchell; Voravit Ratanatharathorn; Roberto Rodriguez; Daryn Smith; Muneer H Abidi; Joseph Primo Uberti
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.
Muneer H Abidi; Judith Abrams; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Lawrence George Lum; Voravit Ratanatharathorn; Nishant Tageja; Marie Ventimiglia; Joseph Primo Uberti
Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lois Jeanne Ayash (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Muneer H Abidi; Judith Abrams; Rishi Agarwal; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Abhinav Deol; Lawrence George Lum; Voravit Ratanatharathorn; Nishant Tageja; Marie Ventimiglia; Jeffrey A Zonder; Joseph Primo Uberti
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):56-61.
2012: Zaid Al-Kadhimi; Lois Jeanne Ayash; Wei Chen; Abhinav Deol; Stephen Forman; Zartash Gul; Lawrence George Lum; Alice Mitchell; Voravit Ratanatharathorn; Roberto Rodriguez; Daryn Smith; Muneer H Abidi; Joseph Primo Uberti
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(11):1734-44.
2012: Muneer H Abidi; Judith Abrams; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Lawrence George Lum; Voravit Ratanatharathorn; Nishant Tageja; Marie Ventimiglia; Joseph Primo Uberti
Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(10):2363-9.
2012: Muneer H Abidi; Judith Abrams; Rishi Agarwal; Zaid Al-Kadhimi; Lois Jeanne Ayash; Simon Cronin; Abhinav Deol; Lawrence George Lum; Voravit Ratanatharathorn; Marie Ventimiglia; Jeffrey A Zonder; Joseph Primo Uberti
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1455-61.
2012: M Miceli; S Cronin; George J Alangaden; Lois Jeanne Ayash; Pranatharthi H Chandrasekar
Significant interaction of tacrolimus with ritonavir during allogeneic hematopoietic SCT in an HIV-infected patient.
Bone marrow transplantation 2012;47(8):1140-2.
2012: Muneer H Abidi; Judith Abrams; Zaid Al-Kadhimi; Lois Jeanne Ayash; Abhinav Deol; Zartash Gul; Lawrence George Lum; Stephanie Mellon-Reppen; Voravit Ratanatharathorn; Marie Ventimiglia; Jeffrey A Zonder; Joseph Primo Uberti
Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma.
Journal of chemotherapy (Florence, Italy) 2012;24(3):167-72.
2011: M Norkin; Voravit Ratanatharathorn; Muneer H Abidi; Zaid Al-Kadhimi; Lois Jeanne Ayash; Lawrence George Lum; Joseph Primo Uberti
Large pericardial effusion as a complication in adults undergoing SCT.
Bone marrow transplantation 2011;46(10):1353-6.
2010: Ehab Atallah; Judith Abrams; Lois Jeanne Ayash; Gail Bentley; Muneer H Abidi; Voravit Ratanatharathorn; Joseph Primo Uberti
Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.
American journal of hematology 2010;85(8):579-83.
2008: Rami B Ibrahim; Muneer H Abidi; Lois Jeanne Ayash; Simon M Cronin; Cheryl Cadotte; Jason Mulawa; Pamela A Jacobson; Daryn W Smith; Joseph Primo Uberti; David J Edwards
Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2008;14(3):113-21.
2007: Lois Jeanne Ayash; Voravit Ratanatharathorn; Thomas Braun; Samuel Michael Silver; Christopher M Reynolds; Joseph Primo Uberti
Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
American journal of hematology 2007;82(1):6-14.
2006: Pavan Reddy; Kent J Johnson; Joseph Primo Uberti; Christopher Reynolds; Samuel Michael Silver; Lois Jeanne Ayash; Thomas M Braun; Voravit Ratanatharathorn
Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2006;38(5):351-7.
2005: Joseph Primo Uberti; Lois Jeanne Ayash; Voravit Ratanatharathorn; Samuel Michael Silver; Christopher Reynolds; Michael Becker; Pavan Reddy; Kenneth R Cooke; Gregory Yanik; Joel Whitfield; Dawn Jones; Raymond J Hutchinson; Thomas Braun; James L M Ferrara; John E Levine
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):680-7.
2004: Joseph Primo Uberti; Lois Jeanne Ayash; Thomas Braun; Christopher Reynolds; Samuel Michael Silver; Voravit Ratanatharathorn
Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
Bone marrow transplantation 2004;34(5):425-31.
2004: Laura A Dawson; Naoyuki G Saito; Voravit Ratanatharathorn; Joseph Primo Uberti; Paul T Adams; Lois Jeanne Ayash; Christopher M Reynolds; Samuel Michael Silver; Matthew Schipper; Allen S Lichter; Avraham Eisbruch
Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
International journal of radiation oncology, biology, physics 2004;59(1):208-18.
2004: Pavan Reddy; Robertson D Davenport; Voravit Ratanatharathorn; Christopher Reynolds; Samuel Michael Silver; Lois Jeanne Ayash; James L M Ferrara; Joseph Primo Uberti
West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation.
Bone marrow transplantation 2004;33(1):109-12.
2003: Voravit Ratanatharathorn; Lois Jeanne Ayash; Christopher Reynolds; Samuel Michael Silver; Pavan Reddy; Michael Becker; James L M Ferrara; Joseph Primo Uberti
Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(8):505-11.
2003: John E Levine; Joseph Primo Uberti; Lois Jeanne Ayash; Christopher Reynolds; James L M Ferrara; Samuel Michael Silver; Thomas Braun; Gregory Yanik; Raymond J Hutchinson; Voravit Ratanatharathorn
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):189-97.
2001: Lois Jeanne Ayash; M Clarke; P Adams; James L M Ferrara; Voravit Ratanatharathorn; C Reynolds; Blake J Roessler; Samuel Michael Silver; Myla S Strawderman; Joseph Primo Uberti; Max S Wicha
Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
Human gene therapy 2001;12(16):2023-5.
2001: Voravit Ratanatharathorn; Lois Jeanne Ayash; Hillard M Lazarus; J Fu; Joseph Primo Uberti
Chronic graft-versus-host disease: clinical manifestation and therapy.
Bone marrow transplantation 2001;28(2):121-9.
2001: Lois Jeanne Ayash; M Clarke; Samuel Michael Silver; Thomas Braun; Joseph Primo Uberti; Voravit Ratanatharathorn; Christopher Reynolds; James L M Ferrara; E R Broun; Paul T Adams
Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Bone marrow transplantation 2001;27(9):939-47.
2001: Christopher Reynolds; Voravit Ratanatharathorn; P Adams; Thomas Braun; Samuel Michael Silver; Lois Jeanne Ayash; E Carson; Avraham Eisbruch; Laura A Dawson; Kevin T McDonagh; James L M Ferrara; Joseph Primo Uberti
Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
Bone marrow transplantation 2001;27(8):801-7.
2001: Anthony D Elias; Paul Richardson; David Avigan; Joseph G Ibrahim; Robin M Joyce; George D Demetri; J Levine; D Warren; T Arthur; E Reich; C Wheele; Emil Frei; Lois Jeanne Ayash
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
Bone marrow transplantation 2001;27(3):269-78.
2000: S Cronin; Joseph Primo Uberti; Lois Jeanne Ayash; C Raith; Voravit Ratanatharathorn
Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2000;26(11):1247-9.
2000: Patrick J Stiff; J Veum-Stone; Hillard M Lazarus; Lois Jeanne Ayash; J R Edwards; A Keating; J P Klein; David J Oblon; Thomas C Shea; S Thomé; Mary M Horowitz
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report.
Annals of internal medicine 2000;133(7):504-15.
2000: Voravit Ratanatharathorn; E Carson; Christopher Reynolds; Lois Jeanne Ayash; John E Levine; Gregory Yanik; Samuel Michael Silver; James L M Ferrara; Joseph Primo Uberti
Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.
Annals of internal medicine 2000;133(4):275-9.
1999: A Elias; Joseph G Ibrahim; Arthur T Skarin; C Wheeler; Mary McCauley; Lois Jeanne Ayash; Paul Richardson; Lowell E Schnipper; Karen Antman; Emil Frei
Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1175.
1998: Anthony D Elias; C Wheeler; Lois Jeanne Ayash; Gary Schwartz; Joseph G Ibrahim; L Mills; Mary McCauley; C Norman Coleman; Diane Warren; Lowell E Schnipper; Karen Antman; Beverly A Teicher; Emil Frei
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1443-9.
1998: Lois Jeanne Ayash; A Elias; Joseph G Ibrahim; Gary Schwartz; C Wheeler; E Reich; Cathy Lynch; Diane Warren; C Shapiro; Paul Richardson; David D Hurd; Lowell E Schnipper; Emil Frei; Karen Antman
High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1000-7.
1997: C Wheeler; C Eickhoff; A Elias; Joseph G Ibrahim; Lois Jeanne Ayash; Mary McCauley; Peter M Mauch; Gary Schwartz; Joseph P Eder; R Mazanet; James L M Ferrara; I J Rimm; Eva C Guinan; BE Bierer; G Gilliland; Winthrop H Churchill; K Ault; S Parsons; Karen Antman; Lowell E Schnipper; I Tepler; L Gaynes; Emil Frei; Marshall E Kadin; Joseph H Antin
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):98-106.
1997: Charles L Shapiro; Lois Jeanne Ayash; Iain Webb; Rebecca Gelman; J Keating; L Williams; George D Demetri; P Clark; A Elias; David B Duggan; Daniel F Hayes; David D Hurd; I Craig Henderson
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):674-83.
1996: Lois Jeanne Ayash; A Elias; Gary Schwartz; C Wheeler; Joseph G Ibrahim; Beverly A Teicher; E Reich; Diane Warren; C Lynch; Paul Richardson; Lowell E Schnipper; Emil Frei; Karen Antman
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2984-92.
1996: Iain Webb; C E Eickhoff; Anthony D Elias; Lois Jeanne Ayash; C A Wheeler; G N Schwartz; George D Demetri; Kenneth C Anderson
Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collections.
Transfusion 1996;36(2):160-7.
1996: Beverly A Teicher; S A Holden; D A Goff; J E Wright; O Tretyakov; Lois Jeanne Ayash
Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
Cancer chemotherapy and pharmacology 1996;38(6):553-60.
1995: Richard J Benjamin; L Linsley; Jeffrey D Axelrod; Winthrop H Churchill; Colin A Sieff; Larry N Shulman; A Elias; Lois Jeanne Ayash; M E Malachowski; Lynne Uhl
The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.
Transfusion 1995;35(10):837-44.
1995: Lois Jeanne Ayash; C Wheeler; D Fairclough; Gary Schwartz; E Reich; Diane Warren; Lowell E Schnipper; Karen Antman; Emil Frei; A Elias
Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):2043-9.
1995: Anthony D Elias; Lois Jeanne Ayash; C Wheeler; Gary Schwartz; I Tepler; R Gonin; Mary McCauley; R Mazanet; Lowell E Schnipper; Emil Frei
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Bone marrow transplantation 1995;15(3):373-9.
1995: S A Holden; B A Teicher; Lois Jeanne Ayash; E Frei
A preclinical model for sequential high-dose chemotherapy.
Cancer chemotherapy and pharmacology 1995;36(1):61-4.
1995: J E Wright; O Tretyakov; Lois Jeanne Ayash; A Elias; Andre Rosowsky; Emil Frei
Analysis of 4-hydroxycyclophosphamide in human blood.
Analytical biochemistry 1995;224(1):154-8.
1994: Anthony D Elias; Lois Jeanne Ayash; C Wheeler; Gary Schwartz; I Tepler; Mary McCauley; R Mazanet; Lowell E Schnipper; Emil Frei; Karen Antman
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.
Seminars in oncology 1994;21(5 Suppl 12):83-5.
1994: Lois Jeanne Ayash
High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer.
Cancer 1994;74(1 Suppl):532-5.
1994: Lois Jeanne Ayash; A Elias; M Hunt; George D Demetri; C Wheeler; I Tepler; Gary Schwartz; R Mazanet; E Reich; Mary McCauley
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
British journal of haematology 1994;87(1):153-61.
1994: Karen Antman; Lois Jeanne Ayash; A Elias; C Wheeler; Gary Schwartz; R Mazanet; I Tepler; Lowell E Schnipper; Emil Frei
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
Journal of the National Cancer Institute. Monographs 1994;(16):91-4.
1994: Lois Jeanne Ayash; A Elias; C Wheeler; E Reich; Gary Schwartz; R Mazanet; I Tepler; Diane Warren; C Lynch; R Gonin
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):37-44.
1993: C Wheeler; M Strawderman; Lois Jeanne Ayash; Winthrop H Churchill; B E Bierer; A Elias; D G Gilliland; Karen Antman; Eva C Guinan; Joseph P Eder
Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1085-91.
1993: Anthony D Elias; Lois Jeanne Ayash; Emil Frei; Arthur T Skarin; M Hunt; C Wheeler; Gary Schwartz; R Mazanet; I Tepler; Joseph P Eder
Intensive combined modality therapy for limited-stage small-cell lung cancer.
Journal of the National Cancer Institute 1993;85(7):559-66.
1993: Anthony D Elias; Lois Jeanne Ayash; Arthur T Skarin; C Wheeler; Gary Schwartz; R Mazanet; I Tepler; Lowell E Schnipper; Emil Frei; Karen Antman
High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer.
Chest 1993;103(4 Suppl):433S-435S.
1993: Lois Jeanne Ayash; A Elias; C Wheeler; I Tepler; Gary Schwartz; Lowell E Schnipper; Emil Frei; Karen Antman
High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Journal of hematotherapy 1993;2(4):507-11.
1993: Anthony D Elias; Lois Jeanne Ayash; I Tepler; C Wheeler; Gary Schwartz; R Mazanet; Lowell E Schnipper; Emil Frei; Karen Antman
The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
Journal of hematotherapy 1993;2(3):377-82.
1992: Michael Seiden; A Elias; Lois Jeanne Ayash; M Hunt; Joseph P Eder; Lowell E Schnipper; Emil Frei; K H Antman
Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens.
Bone marrow transplantation 1992;10(1):57-63.
1992: Lois Jeanne Ayash; J E Wright; O Tretyakov; R Gonin; A Elias; C Wheeler; Joseph P Eder; Andre Rosowsky; Karen Antman; Emil Frei
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):995-1000.
1992: Anthony D Elias; Lois Jeanne Ayash; Kenneth C Anderson; M Hunt; C Wheeler; Gary Schwartz; I Tepler; R Mazanet; C Lynch; S Pap
Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.
Blood 1992;79(11):3036-44.
1992: Karen Antman; Lois Jeanne Ayash; A Elias; C Wheeler; M Hunt; Joseph P Eder; Beverly A Teicher; J Critchlow; J Bibbo; Lowell E Schnipper
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):102-10.
1991: Lois Jeanne Ayash; T Korbut; T S Herman; Beverly A Teicher
Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.
Cancer letters 1991;61(1):7-14.
1991: Anthony D Elias; R Mazanet; C Wheeler; Kenneth C Anderson; Lois Jeanne Ayash; Gary Schwartz; I Tepler; S Pap; J Pelaez; M Hunt
GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: two protocols.
Breast cancer research and treatment 1991;20 Suppl():S25-9.
1991: Lois Jeanne Ayash; Karen Antman; B D Cheson
A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors.
Oncology (Williston Park, N.Y.) 1991;5(3):25-33; discussion 33, 36, 41.
1991: Anthony D Elias; Lois Jeanne Ayash; Joseph P Eder; C Wheeler; J Deary; L Weissman; S Schryber; M Hunt; J Critchlow; Lowell E Schnipper
A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(2):320-7.
1991: Anthony D Elias; Lois Jeanne Ayash; Joseph P Eder; C Wheeler; J Deary; L Weissman; M Hunt; J Critchlow; Lowell E Schnipper; Emil Frei
Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study.
Journal of cancer research and clinical oncology 1991;117 Suppl 4():S208-13.
1991: Joseph P Eder; Anthony D Elias; Lois Jeanne Ayash; C A Wheeler; Thomas C Shea; Lowell E Schnipper; E Frei; K H Antman
A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients.
Cancer chemotherapy and pharmacology 1991;29(1):61-5.
1990: Lois Jeanne Ayash; M Hunt; Karen Antman; Lee M Nadler; C Wheeler; Tak Takvorian; A Elias; Joseph H Antin; T Greenough; Joseph P Eder
Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1699-706.
1990: Karen Antman; Joseph P Eder; A Elias; Lois Jeanne Ayash; Thomas C Shea; L Weissman; J Critchlow; S M Schryber; Colin B Begg; Beverly A Teicher
High-dose thiotepa alone and in combination regimens with bone marrow support.
Seminars in oncology 1990;17(1 Suppl 3):33-8.